Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 5

Results: 34

Animal models of acute myelogenous leukaemia-development, application and future perspectives.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 687, doi. 10.1038/sj.leu.2403670

By:

Mc Cormack, E.;
Bruserud, Ø;
Gjertsen, B. T.

Publication type:

Article

High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 734, doi. 10.1038/sj.leu.2403673

By:

Sutcliffe, M. J.;
Shuster, J. J.;
Sather, H. N.;
Camitta, B. M.;
Pullen, J.;
Schultz, K. R.;
Borowitz, M. J.;
Gaynon, P. S.;
Carroll, A. J.;
Heerema, N. A.

Publication type:

Article

Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia.

Published in:

2005

By:

Furtner, M.;
Straub, R. H.;
Krüger, S.;
Schwarz, H.

Publication type:

Letter

Absence of ATM hypermethylation in mantle cell and follicular lymphoma.

Published in:

2005

By:

Chim, C. S.;
Wong, K. Y.;
Loong, F.;
Srivastava, G.

Publication type:

Letter

Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in‘normal’phenotype cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 862, doi. 10.1038/sj.leu.2403678

By:

Chen, G.;
Zeng, W.;
Maciejewski, J. P.;
Kcyvanfar, K.;
Billings, E. M.;
Young, N. S.

Publication type:

Article

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 776, doi. 10.1038/sj.leu.2403680

By:

Malcovati, L.;
Della Porta, M. G.;
Lunghi, M.;
Pascutto, C.;
Vanelli, L.;
Travaglino, E.;
Maffioli, M.;
Bernasconi, P.;
Lazzarino, M.;
Invernizzi, R.;
Cazzola, M.

Publication type:

Article

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 721, doi. 10.1038/sj.leu.2403689

By:

ten Bosch, J. van der Werff;
Suciu, S.;
Thyss, A.;
Bertrand, Y.;
Norton, L.;
Mazingue, F.;
Uyttebroeck, A.;
Lutz, P.;
Robert, A.;
Boutard, P.;
Ferster, A.;
Plouvier, E.;
Maes, P.;
Munzer, M.;
Plantaz, D.;
Dresse, M.-F.;
Philippet, P.;
Sirvent, N.;
Waterkeyn, C.;
Vilmer, E.

Publication type:

Article

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 829, doi. 10.1038/sj.leu.2403682

By:

Fukushima, T.;
Miyazaki, Y.;
Honda, S.;
Kawano, F.;
Moriuchi, Y.;
Masuda, M.;
Tanosaki, R.;
Utsunomiya, A.;
Uike, N.;
Yoshida, S.;
Okamura, J.;
Tomonaga, M.

Publication type:

Article

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen.

Published in:

2005

By:

Kennedy, G. A.;
Durrant, S.;
Butler, J.;
Morton, J.;
Western, R.;
Bartlett, M. L.;
Allison, R.;
MacFarlane, D. J.

Publication type:

Letter

Regulation of glucocorticoid receptor steroid binding and trafficking by the hsp90/hsp70-based chaperone machinery: implications for clinical intervention.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 710, doi. 10.1038/sj.leu.2403687

By:

Murphy, P. J. M.

Publication type:

Article

Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 767, doi. 10.1038/sj.leu.2403688

By:

Chen, B.;
Zhao, W.-L.;
Jin, J.;
Xue, Y.-Q.;
Cheng, X.;
Chen, X.-T.;
Cui, J.;
Chen, Z.-M.;
Cao, Q.;
Yang, G.;
Yao, Y.;
Xia, H.-L.;
Tong, J.-H.;
Li, J.-M.;
Chen, J.;
Xiong, S.-M.;
Shen, Z.-X.;
Waxman, S.;
Chen, Z.;
Chen, S.-J.

Publication type:

Article

mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 727, doi. 10.1038/sj.leu.2403681

By:

Tissing, W. J. E.;
Meijerink, J. P. P.;
den Boer, M. L.;
Brinkhof, B.;
Pieters, R.

Publication type:

Article

Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 759, doi. 10.1038/sj.leu.2403694

By:

Jahrsdörfer, B.;
Wooldridge, J. E.;
Blackwell, S. E.;
Taylor, C. M.;
Link, B. K.;
Weiner, G. J.

Publication type:

Article

Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 806, doi. 10.1038/sj.leu.2403684

By:

Prima, V.;
Gore, L.;
Caires, A.;
Boomer, T.;
Yoshinari, M.;
Imaizumi, M.;
Varella-Garcia, M.;
Hunger, S. P.

Publication type:

Article

ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.

Published in:

2005

By:

Nigten, J.;
Breems-de Ridder, M. C.;
Erpelinck-Verschueren, C. A. J.;
Nikoloski, G.;
van der Reijden, B. A.;
van Wageningen, S.;
van Hennik, P. B.;
de Witte, T.;
Löwenberg, B.;
Jansen, J. H.;
Löwenberg, B

Publication type:

journal article

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.

Published in:

2005

By:

Passamonti, F.;
Pietra, D.;
Rumi, E.;
Arcaini, L.;
Della Porta, M. G.;
Malcovati, L.;
Pascutto, C.;
Lazzarino, M.;
Cazzola, M.

Publication type:

Letter

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.

Published in:

2005

By:

Marafioti, T.;
Pozzobon, M.;
Hansmann, M.-L.;
Gaulard, P.;
Barth, T. F.;
Copie-Bergman, C.;
Roberton, H.;
Ventura, R.;
Martín-Subero, J. I.;
Gascoyne, R. D.;
Pileri, S. A.;
Siebert, R.;
Hsi, E. D.;
Natkunam, Y.;
Möller, P.;
Mason, D. Y.;
Martín-Subero, J I;
Möller, P

Publication type:

journal article

CD56dimCD16neg cells are responsible for natural cytotoxicity against tumor targets.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 835, doi. 10.1038/sj.leu.2403704

By:

Penack, O.;
Gentilini, C.;
Fischer, L.;
Asemissen, A. M.;
Scheibenbogen, C.;
Thiel, E.;
Uharek, L.

Publication type:

Article

The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 707, doi. 10.1038/sj.leu.2403705

By:

Uhrberg, M.

Publication type:

Article

Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia.

Published in:

2005

By:

Vaskova, M.;
Mejstrikova, E.;
Kalina, T.;
Martinkova, P.;
Omelka, M.;
Trka, J.;
Stary, J.;
Hrusak, O.

Publication type:

Letter

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 750, doi. 10.1038/sj.leu.2403707

By:

Schroers, R.;
Griesinger, F.;
Trümper, L.;
Haase, D.;
Kulle, B.;
Klein-Hitpass, L.;
Sellmann, L.;
Dührsen, U.;
Dürig, J.

Publication type:

Article

Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy.

Published in:

2005

By:

Doubek, M.;
Brychtova, Y.;
Berkovcova, J.;
Krejci, M.;
Palasek, I.;
Dvorakova, D.;
Mayer, J.

Publication type:

Letter

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 851, doi. 10.1038/sj.leu.2403709

By:

Deloose, S. T. P.;
Smit, L. A.;
Pals, F. T.;
Kersten, M.-J.;
van Noesel, C. J. M.;
Pals, S. T.

Publication type:

Article

Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide.

Published in:

2005

By:

Dogan, A.;
Ngu, L. S. P.;
Ng, S. H.;
Cervi, P. L.

Publication type:

journal article

Gadd45a acts as a modifier locus for lymphoblastic lymphoma.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 847, doi. 10.1038/sj.leu.2403711

By:

Hollander, M. C.;
Patterson, A. D.;
Salvador, J. M.;
Anver, M. R.;
Hunger, S. P.;
Fornace Jr., A. J.

Publication type:

Article

Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 713, doi. 10.1038/sj.leu.2403714

By:

Primo, D.;
Tabernero, M. D.;
Perez, J. J.;
Rasillo, A.;
Sayagués, J. M.;
Espinosa, A. B.;
Lopez-Berges, M. C.;
García-Sanz, R.;
Gutierrez, N. C.;
Hernandez, J. M.;
Romero, M.;
Osuna, C. S.;
Giralt, M.;
Barbon, M.;
San Miguel, J. F.;
Orfao, A.

Publication type:

Article

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.

Published in:

2005

By:

Tobin, G.;
Skogsberg, Å.;
Thunberg, U.;
Laurell, A.;
Åleskog, A.;
Merup, M.;
Sundström, C.;
Roos, G.;
Nilsson, K.;
Rosenquist, R.

Publication type:

Letter

HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 841, doi. 10.1038/sj.leu.2403716

By:

Nagel, S.;
Scherr, M.;
Quentmeier, H.;
Kaufmann, M.;
Zaborski, M.;
Drexler, H. G.;
MacLeod, R. A. F.

Publication type:

Article

Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 784, doi. 10.1038/sj.leu.2403717

By:

Paquet, C.;
Sané, A.-T.;
Beauchemin, M.;
Bertrand, R.

Publication type:

Article

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 792, doi. 10.1038/sj.leu.2403722

By:

Roche-Lestienne, C.;
Lepers, S.;
Soenen-Cornu, V.;
Kahn, J.-E.;
Laï, J.-L.;
Hachulla, E.;
Drupt, F.;
Demarty, A.-L.;
Roumier, A.-S.;
Gardembas, M.;
Dib, M.;
Philippe, N.;
Cambier, N.;
Barete, S.;
Libersa, C.;
Bletry, O.;
Hatron, P.-Y.;
Quesnel, B.;
Rose, C.;
Maloum, K.

Publication type:

Article

High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

Published in:

2005

By:

Baron, F.;
Maris, M. B.;
Storer, B. E.;
Sandmaier, B. M.;
Panse, J. P.;
Chauncey, T. R.;
Sorror, M.;
Little, M.-T.;
Maloney, D. G.;
Storb, R.;
Heimfeld, S.

Publication type:

journal article

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation.

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 814, doi. 10.1038/sj.leu.2403719

By:

Zeiser, R.;
Spyridonidis, A.;
Wäsch, R.;
Ihorst, G.;
Grüllich, C.;
Bertz, H.;
Finke, J.

Publication type:

Article

Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance

Published in:

Leukemia (08876924), 2005, v. 19, n. 5, p. 741, doi. 10.1038/sj.leu.2403720

By:

Lane, B. S.;
Mensah, A. A.;
Lin, K.;
Pettitt, A. R.;
Sherrington, P. D.

Publication type:

Article

Severe irreversible bilateral hearing loss after bortezomib (VELCADE®) therapy in a multiple myeloma (MM) patient.

Published in:

2005

By:

Engelhardt, M.;
Müller, A. M. S.;
Maier, W.;
Wäsch, R.

Publication type:

Letter

Works matching IS 08876924 AND DT 2005 AND VI 19 AND IP 5

Animal models of acute myelogenous leukaemia-development, application and future perspectives.

Levels of soluble CD137 are enhanced in sera of leukemia and lymphoma patients and are strongly associated with chronic lymphocytic leukemia.

Absence of ATM hypermethylation in mantle cell and follicular lymphoma.

Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis/immune response in‘normal’phenotype cells.

Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome.

Value of intravenous 6-mercaptopurine during continuation treatment in childhood acute lymphoblastic leukemia and non-Hodgkin's lymphoma: final results of a randomized phase III trial (58881) of the EORTC CLG.

Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma.

Outcome of myeloablative allogeneic stem cell transplantation in multiple myeloma with a 153Sm-EDTMP-based preparative regimen.

Regulation of glucocorticoid receptor steroid binding and trafficking by the hsp90/hsp70-based chaperone machinery: implications for clinical intervention.

Clinical and cytogenetic features of 508 Chinese patients with myelodysplastic syndrome and comparison with those in Western countries.

mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL.

Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity.

Cloning and functional characterization of MEF2D/DAZAP1 and DAZAP1/MEF2D fusion proteins created by a variant t(1;19)(q23;p13.3) in acute lymphoblastic leukemia.

ID1 and ID2 are retinoic acid responsive genes and induce a G0/G1 accumulation in acute promyelocytic leukemia cells.

PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia.

Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma.

CD56<sup>dim</sup>CD16<sup>neg</sup> cells are responsible for natural cytotoxicity against tumor targets.

The CD107 mobilization assay: viable isolation and immunotherapeutic potential of tumor-cytolytic NK cells.

Transfer of genomics information to flow cytometry: expression of CD27 and CD44 discriminates subtypes of acute lymphoblastic leukemia.

Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.

Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy.

High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma.

Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide.

Gadd45a acts as a modifier locus for lymphoblastic lymphoma.

Genetic heterogeneity of BCR/ABL<sup>+</sup> adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics.

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or V<sub>H</sub> gene mutation status in chronic lymphocytic leukaemia.

HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3.

Caspase- and mitochondrial dysfunction-dependent mechanisms of lysosomal leakage and cathepsin B activation in DNA damage-induced apoptosis.

Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics.

High doses of transplanted CD34<sup>+</sup> cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation.

Analysis of V<sub>H</sub> gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significance

Severe irreversible bilateral hearing loss after bortezomib (VELCADE<sup>®</sup>) therapy in a multiple myeloma (MM) patient.